🔍

MGEL - Mangalam Global

📊 NSE: MGEL 🏢 Trading 📅 Last Updated: 12/14/2025 9:33

📢 Recent Corporate Announcements

MGEL Shareholders Approve Employee Stock Option Plan 2026 with 99.99% Majority

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 23 Feb 2026, 04:54 PM

Mangalam Global Enterprise Limited (MGEL) has successfully passed two special resolutions via postal ballot to implement the 'Employee Stock Option Plan 2026'. The resolutions allow for the grant of stock options to eligible employees of both the parent company and its subsidiaries. Shareholders showed overwhelming support, with 99.99% of the 179.1 million votes cast in favor of the plan. This initiative is designed to align employee interests with long-term shareholder value and improve talent retention.

Shareholders approved the 'Employee Stock Option Plan 2026' with 179,099,973 votes (99.9983%) in favor.
The plan covers eligible employees of the company as well as its wholly-owned subsidiaries.
Total voter participation represented 54.35% of the company's total paid-up equity capital.
Only 3,033 votes (0.0017%) were cast against the resolutions, indicating strong consensus.
The voting process was conducted via remote e-voting from January 22 to February 20, 2026.

💡 Investors should view the approval of the ESOP as a positive move for talent retention and alignment of interests. Monitor future filings for the specific number of options granted to assess potential equity dilution.

MGEL Shareholders Approve Employee Stock Option Plan (ESOP) 2026

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 21 Feb 2026, 07:29 PM

Mangalam Global Enterprise Limited (MGEL) has received shareholder approval for the implementation of its 'Employee Stock Option Plan 2026'. The special resolutions, passed via postal ballot on February 20, 2026, allow for the grant of stock options to eligible employees of the company and its subsidiaries. This move is aimed at incentivizing and retaining talent across the group's corporate structure. The voting results were officially declared on February 21, 2026, following a month-long electronic voting period.

Shareholders approved the implementation of 'Employee Stock Option Plan 2026' as a Special Resolution.
The plan extends eligibility to employees of wholly-owned subsidiaries and other subsidiary companies.
The voting period for the postal ballot ran from January 22, 2026, to February 20, 2026.
The resolutions were passed in compliance with Section 110 and 108 of the Companies Act, 2013.

💡 Investors should view this as a positive step for talent retention, though they should monitor future disclosures regarding the total number of options granted to assess potential equity dilution.

Mangalam Global Enterprise Seeks Reclassification of Promoter to Public Category

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 23 Jan 2026, 07:15 PM

Mangalam Global Enterprise Limited (MGEL) has filed an application with BSE and NSE for the reclassification of Ms. Radhika Bansal from the 'Promoter Group' to the 'Public' category. This regulatory step follows the Board of Directors' approval granted on January 13, 2026. The formal application to the stock exchanges was submitted on January 17, 2026, under SEBI (LODR) Regulations. Such moves typically indicate that the individual no longer exercises control or holds a significant management role in the company.

Application submitted to BSE and NSE on January 17, 2026, for promoter reclassification.
Ms. Radhika Bansal to be moved from 'Promoter Group' to 'Public' category.
Board of Directors approved the reclassification request in a meeting held on January 13, 2026.
Process initiated under Regulation 31A(8)(c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 Investors should monitor the final approval from stock exchanges regarding this reclassification. This is a routine regulatory change in shareholding structure and does not impact the company's fundamental operations.

MGEL Incorporates New Subsidiary Mangalam Vanasya Organic with 55% Stake

🟢 POSITIVE ⭐ 6/10

EXPANSION 📅 23 Jan 2026, 05:55 PM

Mangalam Global Enterprise Limited (MGEL) has incorporated a new subsidiary named Mangalam Vanasya Organic Private Limited, effective January 22, 2026. MGEL will hold a 55% controlling stake in the entity through a cash subscription of 55,000 equity shares totaling Rs. 5.50 lakh. The new subsidiary is positioned to focus on the manufacturing and trading of organic, food, and Ayurvedic healthcare products. This strategic move aims to allow the company to pursue these specific business lines in a more focused and dedicated manner.

Incorporation of Mangalam Vanasya Organic Private Limited as a 55% owned subsidiary
Initial cash investment of Rs. 5.50 lakh for 55,000 equity shares at face value
Subsidiary has an authorized and paid-up capital of Rs. 10,00,000
Business focus includes organic products, food products, cereals, and Ayurvedic healthcare
The subsidiary is a fresh incorporation and is yet to commence commercial operations

💡 Investors should track the progress of this new subsidiary as it marks a diversification into the high-growth organic and Ayurvedic sectors. While the initial capital outlay is small, successful execution in these segments could provide long-term value.

MGEL Proposes ESOP 2026 Plan for Grant of 33 Lakh Stock Options

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 21 Jan 2026, 05:24 PM

Mangalam Global Enterprise Limited (MGEL) has initiated a postal ballot to seek shareholder approval for its 'Employee Stock Option Plan 2026'. The plan involves granting up to 33,00,000 stock options to eligible employees of the company and its subsidiaries. Each option will be convertible into one equity share of face value ₹1 upon exercise. The remote e-voting period for this special resolution is scheduled from January 22, 2026, to February 20, 2026.

Proposed 'Employee Stock Option Plan 2026' (ESOP 2026) covers up to 33,00,000 equity shares.
Each stock option is exercisable into one equity share with a face value of ₹1.
The plan extends to eligible employees of both the company and its wholly-owned subsidiaries.
Remote e-voting period runs from January 22, 2026, to February 20, 2026, with a cut-off date of January 16, 2026.
The resolution requires approval as a Special Resolution through a postal ballot process.

💡 Investors should monitor the potential equity dilution resulting from the 33 lakh shares and consider the long-term benefits of employee retention. No immediate action is required as this is a routine management incentive program.

MGEL Q3 Standalone Revenue Jumps 33% YoY to ₹620 Cr; Net Profit at ₹6.61 Cr

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 13 Jan 2026, 06:03 PM

Mangalam Global Enterprise Limited (MGEL) reported a robust 33% YoY growth in standalone revenue for Q3 FY26, reaching ₹620.05 crore. Net profit for the quarter saw a steady increase of 9.8% YoY to ₹6.61 crore. The performance over the nine-month period (9M FY26) was particularly strong, with net profit rising 81.7% to ₹30.21 crore compared to the previous year. Additionally, the board approved a new ESOP-2026 scheme and the reclassification of a promoter holding a 0.30% stake to the public category.

Standalone Revenue from Operations rose 33.1% YoY to ₹620.05 crore in Q3 FY26.
Net Profit for the quarter increased to ₹6.61 crore from ₹6.01 crore in the previous year's corresponding quarter.
9M FY26 Net Profit surged to ₹30.21 crore, an 81.7% increase over the ₹16.63 crore reported in 9M FY25.
Board approved the Employee Stock Option Plan - 2026 (ESOP-2026) to incentivize employees, subject to shareholder approval.
Promoter group member Radhika Bansal (holding 10 lakh shares or 0.30% stake) to be reclassified as a public shareholder.

💡 The company demonstrates strong top-line momentum and significant year-to-date profit growth. Investors should monitor the details of the new ESOP plan for potential equity dilution and the impact of the new Labour Codes on future margins.

MGEL Q3 Standalone Revenue Jumps 33% YoY to ₹620 Cr; Board Approves ESOP-2026

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 13 Jan 2026, 05:59 PM

Mangalam Global Enterprise Limited (MGEL) reported a strong 33% year-on-year growth in standalone revenue from operations, reaching ₹620.05 crore for the quarter ended December 31, 2025. Net profit for the quarter stood at ₹6.61 crore, a 9.8% increase compared to the same period last year. For the nine-month period, the company's net profit nearly doubled to ₹30.21 crore from ₹16.63 crore in the previous year. The board also approved a new Employee Stock Option Plan (ESOP-2026) and the reclassification of a minor promoter holding to the public category.

Revenue from operations increased to ₹62,004.80 Lakhs in Q3 FY26 from ₹46,576.78 Lakhs in Q3 FY25.
Net profit for the nine-month period ended Dec 2025 rose significantly to ₹3,021.13 Lakhs.
Board approved the 'Employee Stock Option Plan - 2026' (ESOP-2026) to be finalized via postal ballot.
Radhika Bansal, holding 10,00,000 shares (0.30% stake), is being reclassified from Promoter to Public category.
Earnings Per Share (EPS) for the nine-month period reached ₹0.92, up from ₹0.53 YoY (adjusted for split).

💡 Investors should note the strong top-line growth and the significant improvement in nine-month profitability. The introduction of an ESOP plan suggests a focus on talent retention, which is generally positive for long-term growth, though investors should watch for potential equity dilution.

Mangalam Global to Open 100 'Neat Everyday' Retail Stores by March 2028

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 13 Jan 2026, 12:09 PM

Mangalam Global Enterprise Limited (MGEL) has announced a significant retail expansion strategy to open 100 new stores under its wellness brand, 'Neat Everyday,' by March 2028. The company reports strong market acceptance for the brand and expects the expansion to be earnings accretive due to higher margins in the wellness segment. This move signals a strategic shift towards a direct-to-consumer retail model to drive long-term profitability. The rollout is planned to occur across the country over the next three years.

Targeting the opening of 100 new retail stores under the 'Neat Everyday' brand by March 2028.
Expansion is driven by strong consumer response and market acceptance of the wellness product range.
Management expects incremental sales to be earnings accretive with higher associated margins.
The initiative aims to significantly increase the company's retail footprint across India.

💡 Investors should track the quarterly progress of store openings and the subsequent impact on the company's EBITDA margins. The shift toward high-margin wellness retail could lead to a valuation re-rating if execution remains on track.

MGEL Incorporates Dubai Subsidiary 'Mangalam Global General Trading FZE' with AED 3.67M Capital

🟢 POSITIVE ⭐ 6/10

EXPANSION 📅 12 Jan 2026, 08:33 PM

Mangalam Global Enterprise Limited (MGEL) has successfully incorporated a new wholly-owned subsidiary in Dubai, UAE, named Mangalam Global General Trading FZE. The subsidiary has been established with an initial share capital of AED 3.67 million (approximately INR 8.3 crore) to focus on general trading activities. This move is a strategic step to expand the company's international footprint and pursue business in a more focused manner. While the entity is yet to commence operations, the trade license was officially issued on December 25, 2025.

100% ownership of the new Dubai-based subsidiary, Mangalam Global General Trading FZE.
Initial capital investment of AED 3,670,000 for the new trading entity.
Trade license issued on December 25, 2025, and formal notification received on January 12, 2026.
The subsidiary will operate in the General Trading industry to drive international business growth.

💡 Investors should view this as a positive step toward global scaling; monitor future quarterly reports for the subsidiary's operational commencement and revenue contribution.

MGEL Submits SEBI Compliance Certificate for Quarter Ended December 31, 2025

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 07 Jan 2026, 02:21 PM

Mangalam Global Enterprise Limited (MGEL) has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, provided by MUFG Intime India Private Limited, confirms that all securities received for dematerialization during the quarter ended December 31, 2025, were processed correctly. It verifies that physical certificates were mutilated and cancelled, and the names of depositories were updated in the register of members. This is a standard procedural filing required by all listed companies in India.

Compliance certificate submitted for the quarter ended December 31, 2025.
Confirmation received from Registrar and Transfer Agent MUFG Intime India Private Limited.
Verified that dematerialized securities are listed on the relevant stock exchanges.
Confirmed that physical share certificates were cancelled and substituted in the register within prescribed timelines.

💡 No action is required as this is a routine regulatory compliance filing. Investors should continue to monitor the company's upcoming quarterly financial performance.

MGEL Announces Trading Window Closure from January 1, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Dec 2025, 06:17 PM

Mangalam Global Enterprise Limited (MGEL) has informed the exchanges that its trading window for insiders will be closed starting January 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the company's financial results for the quarter and nine months ending December 31, 2025. The window will remain closed until 48 hours after the results are declared to the public. The specific date for the board meeting to approve these results will be communicated in due course.

Trading window closure starts from Tuesday, January 1, 2026.
Applies to all designated persons and insiders of the company.
Closure is related to the upcoming Unaudited Financial Results for the quarter ending December 31, 2025.
The window will reopen 48 hours after the official declaration of financial results.
The board meeting date for result approval is yet to be announced.

💡 This is a routine regulatory compliance filing and requires no immediate action from retail investors. Investors should look out for the upcoming board meeting date to assess the company's Q3 performance.

Mangalam Global Enterprise to Close Trading Window from Jan 1, 2026 for Q3 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Dec 2025, 05:52 PM

Mangalam Global Enterprise Limited (MGEL) has announced the closure of its trading window for all insiders and designated persons starting January 1, 2026. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations for the quarter and nine months ending December 31, 2025. The window will remain closed until 48 hours after the declaration of the company's unaudited financial results. The specific date for the Board Meeting to approve these results will be communicated separately in the future.

Trading window closure begins on Tuesday, January 1, 2026.
Applies to financial results for the quarter and nine months ending December 31, 2025.
Window to reopen 48 hours after the official declaration of standalone and consolidated results.
Restricts all designated persons and insiders from dealing in MGEL equity shares during the period.
Board meeting date for result approval to be intimated in due course.

💡 This is a routine regulatory announcement with no immediate impact on stock fundamentals. Investors should monitor for the upcoming board meeting date to assess the company's Q3 financial performance.

MGEL Incorporates Wholly Owned Subsidiary for Nutraceuticals and Wellness Business

🟢 POSITIVE ⭐ 6/10

EXPANSION 📅 26 Dec 2025, 05:37 PM

Mangalam Global Enterprise Limited (MGEL) has announced the incorporation of a new wholly owned subsidiary named Mangalam Neateveryday Private Limited on December 26, 2025. The new entity has an initial authorized and paid-up capital of Rs. 1,00,000, comprising 10,000 equity shares of Rs. 10 each. This subsidiary will focus on the manufacturing and trading of nutraceuticals, wellness, cosmetics, and Ayurvedic healthcare products. This move indicates MGEL's strategic intent to diversify its business portfolio into the high-growth wellness and healthcare sector.

Incorporation of 'MANGALAM NEATEVERYDAY PRIVATE LIMITED' as a 100% wholly owned subsidiary.
Initial paid-up capital of Rs. 1,00,000 consisting of 10,000 equity shares at Rs. 10 each.
Business focus on manufacturing and trading of Nutraceutical, Wellness, Cosmetics, and Ayurvedic products.
The subsidiary was previously proposed to be named Mangalam Nutraceuticals and Wellness Private Limited.
The entity is yet to commence business operations as of the incorporation date.

💡 Investors should monitor the company's capital allocation and execution strategy for this new wellness segment. While the initial investment is small, successful diversification into nutraceuticals could provide a new growth lever for the company.

MGEL: Promoter Group Member Requests Reclassification of 0.30% Stake to Public Category

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 25 Dec 2025, 03:00 PM

Mangalam Global Enterprise Limited (MGEL) has received a formal request from Radhika Bansal to reclassify her status from 'Promoter Group' to 'Public' category. She currently holds 10,00,000 equity shares, representing 0.30% of the company's total paid-up capital. The shares were originally received as a gift from a promoter, and she has confirmed she holds no management role or board seat. This is a standard regulatory procedure under SEBI (LODR) Regulations, 2015.

Request received from Radhika Bansal to move from 'Promoter Group' to 'Public' category.
The shareholder holds 10,00,000 equity shares, equivalent to 0.30% of the paid-up capital.
Shares were acquired via a gift from promoter Mr. Vipin Prakash Mangal.
The applicant confirms no involvement in management, board representation, or special voting rights.
The company will proceed with necessary compliance under SEBI (LODR) Regulation 31A.

💡 This is a minor administrative change involving a very small percentage of shares and does not impact the company's fundamentals. No immediate action is required from investors.

View All MGEL Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue from operations grew 24.07% YoY to INR 2,281.48 Cr in FY25 from INR 1,838.80 Cr in FY24. Standalone revenue increased 25.37% to INR 2,092.53 Cr. The growth is driven by increased scale in the agro-commodity trading and manufacturing segments.

Geographic Revenue Split

Indian operations contributed INR 1,977.82 Cr (approx. 86.7% of total revenue), growing 27.2% YoY. Foreign operations contributed INR 101.87 Cr (approx. 4.5% of total revenue), growing 8.9% YoY from INR 93.51 Cr.

Profitability Margins

The business operates on a high-volume, low-margin model. Gross profit margins for agro-based manufacturing range between 2% to 5%. Net Profit Ratio slightly declined to 1.04% in FY25 from 1.13% in FY24 due to increased tax expenses and finance costs.

EBITDA Margin

Consolidated EBITDA grew 33.39% to INR 65.76 Cr in FY25. Operating margins improved to 2.58% in FY25 from 2.48% in FY24, reflecting better absorption of fixed costs through higher operational scale.

Capital Expenditure

Historical CAPEX included payments for property, plant, and equipment of INR 0.09 Cr in FY25. The company is currently executing a project for Cold-pressed pharma grade Castor oil to enter higher-margin B2B and B2C segments.

Credit Rating & Borrowing

Infomerics Ratings revised the outlook to 'Positive' from 'Stable' and reaffirmed the long-term rating at 'IVR BBB'. Short-term rating is 'IVR A3+'. Finance costs for FY25 were INR 29.71 Cr on a total debt that resulted in a gearing of 1.37x.

⚙️ Operational Drivers

Raw Materials

Castor seeds are the primary raw material, accounting for the bulk of the cost of goods sold (COGS). The availability and pricing of these seeds are the most significant determinants of the company's cost structure.

Import Sources

Primarily sourced from domestic markets in India, specifically Gujarat, which is a major castor seed producing hub.

Key Suppliers

Not disclosed in available documents; however, the company engages with both organized and unorganized market players for procurement.

Capacity Expansion

Current capacity not explicitly stated in MT; however, the company is expanding into 'Cold-pressed pharma grade Castor oil' production to diversify its product mix and improve margin retention.

Raw Material Costs

Raw material costs are highly volatile due to agro-climatic risks. The company faces thin margins (2.99-3.10% for specific agro-products) because it cannot always pass on sudden seed price spikes to customers in a competitive market.

Manufacturing Efficiency

Return on Capital Employed (ROCE) improved to 15.58% in FY25 from 14.17% in FY24, indicating better efficiency in utilizing capital for generating operating profits.

📈 Strategic Growth

Expected Growth Rate

21%

Growth Strategy

Growth is targeted through a shift from pure commodity trading to value-added manufacturing, specifically 'Cold-pressed pharma grade Castor oil' for B2B and B2C segments. The company recently incorporated three wholly-owned subsidiaries, including Mangalam Oleo Speciality Products Private Limited in November 2025, to focus on specialized product lines.

Products & Services

Castor oil (various grades), Cold-pressed pharma grade Castor oil, and other agro-based commodities.

Brand Portfolio

MGEL (Trusted Services Since 1942).

New Products/Services

Cold-pressed pharma grade Castor oil for B2C and B2B markets; expected to provide higher margins than standard industrial castor oil.

Market Expansion

Expansion into Singapore via Mangalam Global (Singapore) Pte. Ltd. and the incorporation of new domestic subsidiaries to handle specialized oleo products.

🌍 External Factors

Industry Trends

The industry is shifting toward specialized, pharma-grade agro-derivatives. MGEL is positioning itself by moving into the B2C segment and cold-pressed oils to escape the 'high-volume low-margin' trap of industrial commodities.

Competitive Landscape

Faces intense competition from both organized and unorganized players, which constrains margin retention and necessitates large-scale operations for financial viability.

Competitive Moat

Moat is based on the 'Mangalam Group' brand (since 1942) and experienced management. However, the moat is narrow due to intense competition and the commodity nature of the primary products.

Macro Economic Sensitivity

Highly sensitive to agricultural output and monsoon cycles. Global economic growth (projected at 2.8% for 2025) and US tariff measures impact export demand for castor-based derivatives.

Consumer Behavior

Increasing demand for pharma-grade and natural oils in the B2C segment is driving the company's shift toward cold-pressed products.

Geopolitical Risks

Trade barriers and new tariff measures by the United States and its trading partners are identified as risks that could negatively impact global economic activity and MGEL's export volumes.

⚖️ Regulatory & Governance

Industry Regulations

Subject to agro-industry regulations and export-import policies. Compliance with growing regulatory norms is a continuing requirement that can impact the timeline for obtaining necessary approvals for new projects.

Environmental Compliance

The company emphasizes maintaining high safety standards across factories and implementing best practices for energy conservation.

Taxation Policy Impact

Effective tax expense for FY25 was INR 8.34 Cr (Consolidated). The company realized a GST refund as an exceptional item in FY25.

Legal Contingencies

Not disclosed in available documents; however, the company maintains internal control systems to ensure transactions are recorded in conformity with established accounting principles.

⚠️ Risk Analysis

Key Uncertainties

Agro-climatic risk (monsoon) and raw material price volatility are the primary uncertainties, with the potential to swing gross margins by 1-2%, which is significant given the 2.58% operating margin.

Geographic Concentration Risk

86.7% of revenue is concentrated in Indian operations, making the company highly dependent on the domestic agricultural economy.

Third Party Dependencies

High dependency on the castor seed farming community and local aggregators for raw material supply.

Technology Obsolescence Risk

Low risk of obsolescence for core products, but the company must upgrade manufacturing processes to meet 'pharma-grade' standards for its new product lines.

Credit & Counterparty Risk

Liquidity is adequate with 29% unutilized working capital limits (INR 170 Cr limit), and the company generates net cash accruals of INR 34.11 Cr to support debt obligations.